Flatiron Health, Inc

New York, New York 10013

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic HER2-negative Breast Cancer, HER2-positive Breast Cancer

Studies at this site

• Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i — Completed
• Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan — Completed